Laloux M, Stalmans W, Hers H G
Eur J Biochem. 1983 Oct 17;136(1):175-81. doi: 10.1111/j.1432-1033.1983.tb07723.x.
The administration of glucocorticoids to mice caused within 3 h an inactivation of glycogen phosphorylase and activation of glycogen synthase in their livers. In a Sephadex filtrate of liver extract, as well as in a purified glycogen fraction obtained from treated mice, but not in the same preparations obtained from control mice, glycogen synthase was activated without previous inactivation of phosphorylase. The initial rate of synthase activation in a Sephadex filtrate was proportional to the rate of glycogen synthesis in vivo in the same animal. When the glycogen fraction was isolated in the presence of soluble starch, it could be separated from phosphorylase, phosphorylase phosphatase and synthase phosphatase. When added to a control Sephadex filtrate, this purified glycogen fraction obtained from prednisolone-treated mice relieved synthase phosphatase from inhibition by phosphorylase a, indicating that it contained a transferable 'deinhibiting factor'. This deinhibiting factor appears to be a protein and was further purified by alkyl-Sepharose or DEAE-cellulose chromatography. Another modification introduced by treatment with prednisolone was that phosphorylase phosphatase was 1.5-2-fold more active than in the liver of control mice. This property however did not correlate with the rate of glycogen synthesis in vivo. Administration of actinomycin D prevented the expression of the glucocorticoid effects on the rate of glycogen synthesis in vivo and on the protein phosphatases in vitro. The deinhibition of synthase phosphatase was also observed in isolated rat hepatocytes incubated in the presence of glucocorticoids, but in these preparations synthase was not activated.
给小鼠注射糖皮质激素后3小时内,可导致其肝脏中的糖原磷酸化酶失活,糖原合酶激活。在肝脏提取物的葡聚糖凝胶滤液中,以及从经处理的小鼠获得的纯化糖原组分中,但在从对照小鼠获得的相同制剂中未观察到,糖原合酶被激活,而磷酸化酶未预先失活。葡聚糖凝胶滤液中合酶激活的初始速率与同一动物体内糖原合成的速率成正比。当在可溶性淀粉存在下分离糖原组分时,它可以与磷酸化酶、磷酸化酶磷酸酶和合酶磷酸酶分离。将从泼尼松龙处理的小鼠获得的这种纯化糖原组分添加到对照葡聚糖凝胶滤液中,可解除合酶磷酸酶受磷酸化酶a的抑制,表明它含有一种可转移的“去抑制因子”。这种去抑制因子似乎是一种蛋白质,并通过烷基琼脂糖或DEAE-纤维素色谱进一步纯化。泼尼松龙处理引入的另一个变化是,磷酸化酶磷酸酶的活性比对照小鼠肝脏中的高1.5 - 2倍。然而,这种特性与体内糖原合成的速率无关。放线菌素D的给药可阻止糖皮质激素对体内糖原合成速率和体外蛋白质磷酸酶的影响的表达。在存在糖皮质激素的情况下孵育的分离大鼠肝细胞中也观察到合酶磷酸酶的去抑制,但在这些制剂中合酶未被激活。